The aesthetics and beauty company, Andimad, which is traded in Tel Aviv, is honored to announce a collaboration between it and the L’Oréal group. As part of the above collaboration, a protocol was developed for performing treatments based on the professional product of the PURE company.
As part of the above cooperation, the company received an initial order from the L’Oreal Group for a product sold to the L’Oreal Group in the amount of hundreds of thousands of euros. In the first phase, the product sold to the L’Oreal Group is intended for marketing in France and China.
The company welcomes the cooperation with one of the largest and most innovative beauty companies in the world and believes that the combination of the company’s solution and the L’Oreal Group’s selected skin care products will provide customers with effective and unique hybrid aesthetic treatments, and increase the number of customers exposed to the company’s and brand.
Endimed, through its subsidiary Andimed Medical, is engaged in the development, production and sale of medical-aesthetic equipment that operates on the basis of radio-wave (RF) -based technology that it has developed.
The aforesaid equipment is intended for rejuvenating and firming the skin of the face and body, for narrowing the perimeters, for treating the scarring of the skin after acne and for treating cellulite, all in a non-invasive or minimally invasive manner.
One of the group’s product lines is marketed to the professional medical market, ie to doctors, medical clinics for aesthetics and aesthetic therapists, who use the company’s products to treat their clients, including the PURE product. A second product line is designed for the home consumer market. The group was able to minimize and adapt its unique technology and apply it in a home device sold to the home consumer whose main purpose is collagen production and consequently reduction of wrinkles and rejuvenation of the facial skin.